Snapshot

DOI:

Effects of age on microvascular function; clinical value of a resistance index in stable angina; vulnerable plaques and adverse events; viewpoints and original research on left atrial appendage occlusion including long-term durability data of the Amplatzer Amulet; and more

From perspectives on left atrial appendage occlusions or original research on the effects of ageing or diabetes and vulnerable plaque to chimney/snorkel stenting during TAV-in-TAV – there’s something for everyone in this issue of EuroIntervention...take a look.

Effects of age on microvascular function

Tijn P.J. Jansen, Peter Damman and colleagues use continuous thermodilution to assess whether age has an effect on microvascular function in patients with normal coronary arteries. They demonstrate an age-dependent increase in hyperaemic microvascular resistance and a decrease in microvascular function, with the latter most evident in patients with smooth coronary arteries.

Clinical value of HSR in stable angina

By using the combined assessment of pressure and flow, the hyperaemic stenosis resistance index may overcome some of the limitations of conventional physiological indices. Vulnerable plaque features and adverse events confirm that hyperaemic stenosis resistance improves the diagnostic accuracy of the detection of ischaemia-inducing lesions and has an important prognostic value for the long-term risk of target vessel failure.

Vulnerable plaque features and adverse events

David del Val, Elvin Kedhi and colleagues examine the prognostic impact of optical coherence tomography-detected vulnerability features (OCT-VFs), either individually or in combination, in predicting the incidence of the lesion-oriented composite endpoint (LOCE) in diabetic patients with non- ischaemic lesions. Thin-cap fibroatheroma was the strongest single predictor of future LOCE events but the risk increased significantly with the simultaneous presence of four OCT-VFs.

Long-term LAAO safety with the Amplatzer Amulet

Lasse Hubertus Tiroke, Jens Erik Nielsen- Kudsk and colleagues evaluate the long- term safety and durability of the Amplatzer Amulet device after left atrial appendage occlusion. Their results suggest that the prevalence and size of peridevice leakage remain stable over time and rarely seal up or progress, underlining the importance of the immediate procedural outcome.

Volume 20 Number 11
Jun 3, 2024
Volume 20 Number 11
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved